PillCam COLON 2© in Crohn’s disease: A new concept of pan-enteric mucosal healing assessment

Table 3 Patient characteristics, Crohn's disease therapy and endoscopic findings

Patient	Age (yr)	Sex	Follow-up (mo)	Therapy	SBCE LS	Index colonoscopy colon findings	PCC2 LS	PCC2 colon findings
1	21	Male	48	Azathioprine 2.5 mg/kg per day	2980	Extensive ulcers and erythema in entire colon	1068	Extensive ulcers in entire colon
2	21	Female	63	Azathioprine 2.5 mg/kg per day Adalimumab 40 mg eow	1440	Extensive ulcers and erythema in entire colon	2336	No lesions
3	26	Male	57	Azathioprine 2.5 mg/kg per day Adalimumab 40 mg eow	1350	Aphtoid ulcers and erythema in the sigmoid	562	No lesions
4	48	Male	33	Azathioprine 2.5 mg/kg per day	1240	Aphtoid ulcers and erythema in the cecum	5392	Extensive ulcers in the ascending and transverse colon
5	24	Male	39	Mesalazine 3 g/d	1104	Aphtoid ulcers in the cecum	1518	Aphtoid ulcers in the cecum
6	27	Female	14	Azathioprine 2.5 mg/kg per day	900	Extensive ulcers and erythema proximal to the splenic flexure	0	Ulcers in the transverse colon
7	18	Male	14	Azathioprine 2.5 mg/kg per day	1690	Extensive ulcers and erythema in entire colon	2336	Ulcers in the cecum, ascending, transverse and descending colon
8	35	Female	22	Azathioprine 2.5 mg/kg per day	314	Aphtoid ulcers and erythema in the cecum	5392	No lesions
9	32	Male	22	Mesalazine 3 g/d	458	Extensive ulcers and erythema in entire colon	0	No lesions
10	46	Female	49	Azathioprine 2.5 mg/kg per day	393	Extensive ulcers and erythema proximal to the splenic flexure	0	No lesions
11	50	Female	65	Azathioprine 2.5 mg/kg per day	225	Ulcers in the sigmoid	8	Ulcerative lesions in the splenic flexure;
12	39	Male	62	Mesalazine 3 g/d	168	Aphtoid ulcers in the cecum and ascending colon	0	No lesions

SBCE: Small bowel capsule endoscopy; LS: Lewis Score; eow: Every other week; PCC2: PillCam COLON 2^©.